Similarly to a previous study (18), our results imply that the detection of intraglomerular IgM and C3 deposits may serve as an additional diagnostic parameter for patients with faster progression of FSGS irrespective of the disease etiology. The gene discussed is C3; the disease is focal segmental glomerulosclerosis.